Indapamide (sustained-release)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Indapamide (sustained-release), covering 2024-07-15 to 2024-07-15. Get the full timeline:
Most recent: Clinical Trial Update: To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan Isoproxil [Phase 3]